StockData
Crescent Biopharma, Inc. logo

Crescent Biopharma, Inc. (CBIO) stock

CBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$13.04−0.46 (-3.41%)

Close on Nov 17, 2026Market cap $484.36MP/E –Yield –

Crescent Biopharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Crescent Biopharma's price to book ratio was 2.5× on Nov 11, 2026, against 1.8× a year earlier. Over the last 5 years it ranged from 1.1× to 484.4×, with a median of 77.2×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20262.5×+1.1
2025Dec 31, 20251.4×−130.4
2024Oct 31, 2024131.8×−194.6
2023Dec 29, 2023326.4×−3.8
2022Dec 30, 2022330.1×+253.0
2021Dec 31, 202177.2×−52.9
2020Dec 31, 2020130.1×−7.2
2019Dec 31, 2019137.3×−50.0
2018Dec 31, 2018187.3×−238.2
2017Nov 30, 2017425.5×+88.5
2016Dec 30, 2016337.0×+113.4
2015Dec 31, 2015223.6×−12.1
2014Dec 31, 2014235.7×–

More Crescent Biopharma figures

See a number that looks wrong?